News

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at sit-down dining stocks, starting with Bloomin' Brands (NASDAQ:BLMN).

Haemonetics has gotten torched over the last six months - since October 2024, its stock price has dropped 20.1% to $63.39 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the sit-down dining industry, including BJ's (NASDAQ:BJRI) and its peers.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the construction and maintenance services industry, including APi (NYSE:APG) and its peers.

Even during a down period for the markets, Privia Health has gone against the grain, climbing to $22.91. Its shares have yielded a 29.3% return over the last six months, beating the S&P 500 by 30.9%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Over the past six months, Wynn Resorts’s shares (currently trading at $83.10) have posted a disappointing 18.6% loss while the S&P 500 was down 1.7%. This may have investors wondering how to approach the situation.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how real estate services stocks fared in Q4, starting with CBRE (NYSE:CBRE).